Koers Nextgen Biomed Ltd TEL AVIV STOCK EXCHANGE
Aandelen
NXGN
IL0010839301
Medische apparatuur, benodigdheden & distributie
Omzet 2021 | - | Omzet 2022 | - | Marktkapitalisatie | 27,18 mln. 103 mln. 25,34 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -2 mln. -7,6 mln. -1,86 mln. | Nettowinst (verlies) 2022 | -8 mln. -30,42 mln. -7,46 mln. | EV/omzet 2021 | - |
Nettoliquiditeiten 2021 | 11,96 mln. 45,48 mln. 11,15 mln. | Nettoliquiditeiten 2022 | 5,24 mln. 19,93 mln. 4,89 mln. | EV/omzet 2022 | - |
K/w-verhouding 2021 |
-21,7
x | K/w-verhouding 2022 |
-3,17
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 92,33% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 48 | 20-11-22 | |
Dalia Mulakandov
DFI | Director of Finance/CFO | 39 | 17-01-23 |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 69 | 08-08-00 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Grossman
BRD | Director/Board Member | 49 | 12-06-22 |
Yaacov Amidror
CHM | Chairman | 75 | 07-01-21 |
Alon Pinkas
BRD | Director/Board Member | 62 | 17-11-22 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+11,94% | 29,7 mld. | |
-33,64% | 2,9 mld. | |
-17,23% | 2,71 mld. | |
+6,12% | 2,14 mld. | |
-1,11% | 1,91 mld. | |
-12,82% | 1,84 mld. | |
-7,22% | 1,42 mld. | |
-2,78% | 1,26 mld. | |
+3,72% | 1,13 mld. |